Find your next paid study

National Heart, Lung, and Blood Institute (NHLBI)NCT05072483

~$10 – $675

Spinal Cord InjuriesLower Motor Neuron Disease

Pilot Study: Dorsal Root Ganglion Stimulation After Spinal Cord Injury-Related Lower Motor Neuron Damage

The purpose of this study is to study sensorimotor circuit activity generated in response to temporarily implanted dorsal root ganglion stimulation by recordin…

Peter J. Grahn, Ph.D.NCT07619300

~$10 – $7,500

Phase 2

A Randomized, Participant- and Investigator-blinded, Controlled, Parallel Group Study to Assess the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LXE408 in Participants With Chronic Chagas Disease Without Severe Organ Dysfunction.

This study is to investigate the ability of LXE408 to clear or reduce the level of parasites in the blood of people with chronic Chagas disease. Participants m…

Chagas Disease

Novartis PharmaceuticalsNCT06632600

DementiaAlzheimer DiseaseVascular Dementia

The BRAIN App (Phase 2 SBIR): Building Relationships Using Artificial Intelligence and Nostalgia

There are currently 6.7 million Americans living with dementia and, without significant breakthroughs, this figure will double to 12.7 million by 2050. There a…

Peripheral Vascular Diseases

Hopeful AgingNCT06298474

Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature (ELEGANCE)

The ELEGANCE Registry's objective is to collect Real-World Data (RWD), including populations previously not represented in Peripheral Vascular Disease (PVD) tr…

Boston Scientific CorporationNCT04674969

~$10 – $1,050

Phase 1

Phase 1 First-in-Human, Dose Escalation and Dose Expansion Study of RYZ401, a Novel Radiopharmaceutical Therapy Labeled With Actinium-225, in Subjects With Neuroendocrine Tumors and Other Solid Tumors Expressing Somatostatin Receptors.

The primary objectives are to determine the recommended Phase 2 dose (RP2D) and optimal treatment regimen, characterize safety and tolerability, and evaluate p…

GEP-NETGastroenteropancreatic Neuroendocrine TumorGastroenteropancreatic Neuroendocrine Tumor Disease+6 more

RayzeBio, Inc.NCT07165132

Phase 2

A Phase 2 Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of WIN378 in Participants With Moderate - Severe Chronic Obstructive Pulmonary Disease

This study is trying to identify the right dose of a long-acting medicine called WIN378 for people with moderate - severe chronic obstructive pulmonary disease…

COPD (Chronic Obstructive Pulmonary Disease)

~$10 – $7,500

Windward BioNCT07646587

DementiaAlzheimer DiseaseVascular Dementia

Making Connections Thru Music: A Group Music Therapy-Based Intervention for Persons With Dementia

Healthcare systems around the world, including within the United States, have long-established shortages of trained caregivers. The American Health Care Associ…

Hopeful AgingNCT06079216

Type 2 DiabetesLiver Disease

Effect of Behavioral Intervention/Therapy to Reduce Diabetes and Liver Disease Risk Through Prescribed Digital Therapeutics Enabled by AI/ML Powered Predictive Analytics

This clinical trial aims to find out if a digital behavioral program, delivered through the SIPPA digital therapeutics app, can help improve blood sugar contro…

SIPPA Solutions INCNCT07032311

Phase 3

A Prospective, Multicenter, Open-label, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Prophylactic VGA039 in Adolescent and Adult Patients With Von Willebrand Disease (VIVID-6)

This is a phase 3 study that will evaluate subcutaneous (SC) VGA039 in patients with von Willebrand Disease (VWD)

Von Willebrand Disease (VWD)

Vega Therapeutics, IncNCT07115004

Automated Daytime Adaptive Deep Brain Stimulation Parameter Optimization in Patients Implanted With Percept Neurostimulator

Parkinson's disease (PD) affects \~1% of people over 60 years old, is highly disabling and represents a large economic burden. While dopaminergic medications e…

PD - Parkinson's Disease

University of California, San FranciscoNCT07682311

~$10 – $5,625

Crohn's DiseaseUlcerative ColitisInflammatory Bowel Diseases

Digital Mind Body Intervention Among Black and Hispanic Patients Living With Inflammatory Bowel Disease

The bidirectional effects between psychological distress and inflammatory bowel disease (IBD) activity mean that not only does increased IBD activity trigger p…